Key facts
- It has raised $12.2M; the latest was Later Stage VC ($5.3M) in Dec 2024.
- Notable investors include DHKN.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Ceroflo
- ·The full record, as it builds
Funding rounds
No funding rounds for Ceroflo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ceroflo
Manufacturer of catheter-delivered neurovascular implants designed to treat Intracranial Atherosclerotic Disease (ICAD). The equipment works by opening up the blocked artery caused by high cholesterol plaque and restoring blood flow to the brain, enabling patients to improve symptoms and treatment of ICAD, such as stroke and cognitive decline.
- Sector
- Healthcare
- HQ
- Galway, Ireland
- Founded
- 2017
- Employees
- 6
- Website
- ceroflo.com/
- Ownership
- Privately Held (backing)
Ceroflo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ceroflo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ceroflo in its N-PORT filings yet. We sweep new filings monthly.